A data center at a medical university drives research, education, and patient care by managing key data, supporting innovation, and enabling data-driven decisions.
| Sr. No. | Type of data | Last updated | Data available (years) | Focal person |
|---|---|---|---|---|
| 1 | Hepatitis C | Dec-24 | 2006- 2023 | Current focal person: Dr. Misbah Noureen, 0313-5324954 (Previous focal person: Dr. Aqsa, 0300-4064396) |
| 2 | Dengue | Dec-24 | 2022-2024 | Focal Person: Dr. Safiullah, 0321-5798050 |
| 3 | ICU Infections | Sep-24 | 2019 | Focal Person: Dr. Kiran (0335-9627484) Prof. Dr. Mujeeb khan |
| 4 | Radiology | Aug-24 | 2012- 2023 | Focal person: Prof. Dr. Nasir, 0333-5142295 |
| 5 | Oncology | Mar, 2025 | 2022-2025 | Current focal person: Dr. Muhammad Hamza, 0333-8173512 (Previous focal person: Dr. Umer Afzal, 0335-9627484) |
| 6 | COVID-19 | Sep, 2024 | 2020 | Focal person: Dr. Mehwish (Previous focal person: Dr. Khuzeema) |
| 7 | Diabetes | Feb-25 | 2024-2025 | Focal Person: Dr Madeeha Nazar, 0332-7777658 (HbA1c: 2020- 2024),Prof. Dr. Shehzad Manzoor |
| 8 | Diabetic Retinopathy | Jun-25 | 2024-2024 | Focal Person: Dr. Sidra Jabeen |
Hepatitis C is a major health issue in Pakistan, contributing to liver disease and related complications. Since 2006, at RMU a comprehensive dataset of 9,392 patients has been maintained to monitor HCV progression and treatment response.
A comprehensive clinical database of 9868 dengue patients (2022–2024) captures detailed demographic, clinical, diagnostic, and laboratory data to support research and public health strategies in Pakistan.
Dengue Data base provides valuable insights into disease patterns, comorbidities, and outcomes, aiding effective dengue management.
A diabetes patient registry supervised by Dr. Madeeha Nazir tracks data from 18277 patients (2024–2025), offering insights into demographics, treatment, lab results, complications, and lifestyle factors.
This robust dataset supports clinical research, and policy-making to enhance diabetes care and outcomes in Pakistan.
According to World Health Organization a HbA1c of 6.5% is recommended as the cut point for diagnosing diabetes.
Supervised by Dr. Kiran, this ICU-based dataset of 1,949 samples (2019–2024) tracks antimicrobial resistance patterns in 14 key bacterial species and their susceptibility to 15 antibiotics.
It supports infection control and antimicrobial stewardship in critical care settings.
The oncology registry, maintained from August 2022 to March 2025 under Dr. Muhammad Hamza, documents data from 724 cancer patients, including demographic and clinical details.
It supports cancer trend analysis, referral tracking, and outcome evaluation, strengthening evidence-based oncology care and research.
This dataset, updated in September 2024, includes comprehensive clinical and demographic data for 198 patients from 2020.
It captures key indicators such as symptoms, vitals, lab results and outcomes—providing valuable insights for clinical analysis, disease pattern evaluation, and epidemiological research.
Supervised by Prof. Nasir khan, this MRCP dataset of 797 patients (2021–2023) captures detailed biliary measurements, symptoms, and demographics to support research on hepatobiliary disorders. It enables clinical correlation and analysis of bile duct pathology trends over time.
Published Paper
Magnetic resonance cholangiopancreatography (MRCP) based diagnosis of pancreaticobiliary disorders: Three years study at a tertiary care Hospital.
The retinopathy database systematically compiles clinical and demographic information of patients diagnosed with retinal disorders.
It includes data on visual acuity, disease severity, comorbidities, treatment interventions, and outcomes—supporting research, early detection strategies, and evidence-based management of retinal diseases.
The second challenge faced was addressing student fears, depression, and loneliness. Additionally, RMU had to manage shortages of faculty, establish separate classrooms, and develop a specialized curriculum for these students. The faculty graciously embraced all three challenges. Within just four weeks, a dedicated curriculum committee collaborated closely with the Dean of Al-Azhar University and PMDC to design a suitable curriculum, enabling classes to begin promptly
On the directions of Vice Chancellor RMU, Professor Dr. Muhammad Umar (SI, HI), Rawalpindi Medical University organized flood relief medical camps in Buner District.
A medical camp was successfully conducted in the Koz Gokand area of Buner, where a team of RMU doctors provided medical services to more than 400 patients.
This camp was especially significant as the area is located at a far distance from standard health facilities (both government and private), leaving the local population with limited access to healthcare. The initiative has been highly appreciated by the local community, with residents acknowledging that RMU doctors were the first to reach areas that had not yet been served by any other teams.
Rawalpindi Medical University is a public university located in Rawalpindi, Punjab, Pakistan. It is affiliated with three public sector teaching hospitals . It is also listed among the recognized universities and degree awarding institutions by the HEC.
Rawalpindi Medical University, Tipu Road, Chamanzar Colony, Rawalpindi, Pakistan
